Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hester.in | |
Market Cap | 1,430.30 Cr. | |
Enterprise Value(EV) | 1,673.19 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 35.05 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 47.93 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 327.02 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 5.14 | Calculated using Price: 1,680.00 |
Dividend Yield | 0.59 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.85 Cr. | 8,506,865 Shares |
FaceValue | 10 | |
Company Profile | ||
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008. |
1 Day |
|
-0.12% |
1 Week |
|
-2.05% |
1 Month |
|
-6.11% |
3 Month |
|
-5.31% |
6 Month |
|
-14.57% |
1 Year |
|
-33.39% |
2 Year |
|
-17.15% |
5 Year |
|
+7.38% |
10 Year |
|
+1298.83% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 12.88 | 16.73 | 20.56 | 20.38 | 17.57 | 25.59 | 16.38 | 16.16 | 16.00 | |
Return on Capital Employed (%) | 17.78 | 17.26 | 18.98 | 19.75 | 20.20 | 26.64 | 16.53 | 17.33 | 14.02 | |
Return on Assets (%) | 6.89 | 8.84 | 11.08 | 11.43 | 10.10 | 14.97 | 9.04 | 8.70 | 8.03 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 75 | 85 | 102 | 122 | 141 | 177 | 201 | 228 | 260 | 264 | |
Non Curr. Liab. | 20 | 38 | 41 | 48 | 44 | 70 | 97 | 114 | 198 | 244 | |
Curr. Liab. | 45 | 35 | 38 | 38 | 55 | 49 | 83 | 61 | 97 | 109 | |
Minority Int. | 1 | 3 | 5 | 5 | 4 | 4 | 5 | 8 | 7 | 7 | |
Equity & Liab. | 142 | 160 | 186 | 213 | 244 | 299 | 387 | 411 | 562 | 624 | |
Non Curr. Assets | 85 | 100 | 112 | 133 | 146 | 158 | 227 | 250 | 367 | 418 | |
Curr. Assets | 57 | 60 | 74 | 80 | 98 | 142 | 159 | 162 | 195 | 206 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 142 | 160 | 186 | 213 | 244 | 299 | 387 | 411 | 562 | 624 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 69 | 90 | 101 | 123 | 136 | 178 | 183 | 214 | 235 | 255 | |
Other Income | 1 | 0 | 1 | 0 | 3 | 7 | 6 | 5 | 14 | 19 | |
Total Income | 70 | 90 | 102 | 124 | 138 | 185 | 190 | 219 | 249 | 274 | |
Total Expenditure | -45 | -65 | -68 | -82 | -89 | -110 | -128 | -146 | -175 | -206 | |
PBIDT | 25 | 26 | 34 | 41 | 50 | 75 | 62 | 73 | 74 | 68 | |
Interest | -6 | -5 | -4 | -4 | -4 | -7 | -7 | -7 | -4 | -9 | |
Depreciation | -5 | -6 | -6 | -7 | -10 | -12 | -13 | -13 | -17 | -20 | |
Taxation | -4 | -5 | -6 | -8 | -13 | -16 | -10 | -15 | -14 | -12 | |
Exceptional Items | 3 | -3 | |||||||||
PAT | 9 | 13 | 19 | 23 | 23 | 41 | 31 | 35 | 39 | 27 | |
Minority Interest | 0 | 0 | 0 | 1 | 3 | 1 | -2 | 0 | 0 | -2 | |
Share Associate | 0 | 5 | |||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 9 | 14 | 19 | 24 | 26 | 42 | 29 | 34 | 39 | 30 | |
Adjusted EPS | 11 | 16 | 23 | 28 | 30 | 49 | 34 | 40 | 46 | 35 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 12 | 9 | 20 | 19 | 35 | 38 | 47 | 37 | 58 | 9 | |
Cash Fr. Inv. | -23 | -15 | -21 | -13 | -30 | -26 | -22 | -74 | -38 | -117 | |
Cash Fr. Finan. | 10 | 7 | 7 | -7 | 2 | -11 | 3 | 19 | -18 | 112 | |
Net Change | -1 | 2 | 5 | -1 | 6 | 1 | 28 | -19 | 1 | 4 | |
Cash & Cash Eqvt | 2 | 4 | 6 | 5 | 11 | 12 | 41 | 24 | 21 | 25 |
Mon, 06 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Loss of Share certificate details (Duplicate Share request) |
Wed, 08 Feb 2023
Announcement under Regulation 30 (LODR)-Credit Rating Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements) Regulations 2015 ("the Regulations") we would like to inform that CARE Ratings Limited (CARE Ratings) vide its letter dated 7 February 2023 (received electronically) has revised the ratings to the Company. The rating letter issued by the CARE Ratings Limited is enclosed herewith.You are requested to take the above information on your record. |
Wed, 08 Feb 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shaila Bhupendra Gandhi & PACs |
Fri, 24 Mar 2023 |
|
|
|
|
|